Alzheimer’s Society is delighted to announce that Kate Lee, currently Chief Executive Officer at children and young people’s cancer charity CLIC Sargent, will take up the reins as the charity’s new CEO in April 2020.
Researchers presented results from a phase 3 trial of pimavanserin that showed a significant reduction in the risk of relapse into psychosis compared to the placebo.
New analysis has uncovered tht between the last General Election in 2017 and the upcoming December Election, 2.5 million NHS beds were lost due to the social care crisis.
Biogen presented their results on Aducanumab, their newest drug for the treatment of Alzheimer's disease at the CTAD conference 2019 in San Diego, USA.
Two new papers are being published in Science Translational Medicine which shed more light on the mechanism that leads to cognitive ageing in mice and humans.